title: Re: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
authors.forename: Paolo
authors.initials: P
authors.lastname: Giorgi Rossi
authors.forename: Marco
authors.initials: M
authors.lastname: Zappa
mesh_terms: D052685:Alphapapillomavirus / Q000302:isolation & purification*; D003362:Cost-Benefit Analysis; D004279:DNA, Viral / Q000302:isolation & purification*; D019049:Developed Countries; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology; D052161:Human papillomavirus 18 / Q000276:immunology; D006801:Humans; D015994:Incidence; D008403:Mass Screening / Q000191:economics* / Q000379:methods*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D016312:Treatment Refusal; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology
chemical_list: D004279:DNA, Viral; D053918:Papillomavirus Vaccines